Mon, Oct 20, 2014, 10:32 PM EDT - U.S. Markets closed

Recent

% | $
Quotes you view appear here for quick access.

Celldex Therapeutics, Inc. Message Board

  • going1green going1green Mar 7, 2013 7:57 PM Flag

    I Have LINK: Article : Analysts Raising CLDX Target. Roth Capital Says Buy with $16 Target. POSTED.

    US Market Buzz 3/7/13
    Analysts’ call: eBay Inc (NASDAQ:EBAY), Celldex Therapeutics, Inc. (NASDAQ:CLDX)
    March 7, 2013 by Karen Loftus in Technology
    In other news, Leerink Swann has initiated coverage for Celldex Therapeutics, Inc.(NASDAQ:CLDX) with a rating of Outperfrom. It set a price target of $18.

    Howard Liang, an analyst said that the range of Celldex Therapeutics is rare among small and mid-sized biotech enterprises, with 6 entirely owned clinical-stage biologics assets offering multiple shots on goal.

    A number of other companies have also commented on Celldex recently. Oppenheimer analysts have upped their price targets on the Celldex stock to $13 and have rated it an Outperform. Roth Capital analysts have reinstated a Buy rating on the Celldex shares and presently hold a price target of $16 on the stock.
    Cantor Fitzgerald analysts have also increased their price target on the biotech company’s stock to $13 and have rated it a Buy.

    SortNewest  |  Oldest  |  Most Replied Expand all replies
 
CLDX
15.15+0.28(+1.88%)Oct 20 4:00 PMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.